EFFECT OF MODERATE HEPATIC IMPAIRMENT ON THE SAFETY AND PHARMACOKINETICS OF REZAFUNGIN

Ong, V; Sandison, T; Melara, R; Marbury, T; Huguet, J; Jandourek, A; Flanagan, S

CRITICAL CARE MEDICINE, 2021; 49 (1): 334